International Clinical Trial: Protecting Against Lenacapavir Misinformation With Young Women in Gauteng, South Africa ( PROTECT-L)

Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07518914) titled 'Protecting Against Lenacapavir Misinformation With Young Women in Gauteng, South Africa ( PROTECT-L)' on April 1.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Double (Participant, Investigator).

Primary Sponsor: University of Pennsylvania

Condition: Misinformation Lenacapavir

Intervention: Behavioral: Diabetes information

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: April 2026

Target Sample Size: 1500

Countries of Recruitment: South Africa

To know more, visit https://clinicalt...